Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women

Women's Interagency HIV Study

doi:10.1002/cpt.1605

Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women

Women's Interagency HIV Study

Bloomberg School of Public Health

Research output: Contribution to journal › Comment/debate › peer-review

1 Scopus citations

Original language	English (US)
Pages (from-to)	315-318
Number of pages	4
Journal	Clinical pharmacology and therapeutics
Volume	107
Issue number	2
DOIs	https://doi.org/10.1002/cpt.1605
State	Published - Feb 1 2020

ASJC Scopus subject areas

Pharmacology
Pharmacology (medical)

Access to Document

10.1002/cpt.1605

Cite this

@article{e7bbdf0056a44a8ba6f34e5632aabc66,

title = "Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women",

author = "{Women's Interagency HIV Study} and Bani Tamraz and Yong Huang and French, {Audrey L.} and Seble Kassaye and Kathryn Anastos and Nowicki, {Marek J.} and Stephen Gange and Gustafson, {Deborah R.} and Peter Bacchetti and Greenblatt, {Ruth M.} and Hysi, {Pirro G.} and Aouizerat, {Bradley E.}",

note = "Funding Information: University of California San Francisco (UCSF) -Gladstone Center For AIDS Research Grant: Bani Tamraz P30 A1027763; National Institute of Allergy and Infectious Diseases (NIAID): Kathryn Anastos U01-AI-035004; NIAID: Deborah R. Gustafson U01-AI-031834; NIAID: Audrey L. French U01-AI-034993; NIAID: Seble Kassaye U01-AI-034994; NIAID: Ruth M. Greenblatt, Bradley E. Aouizerat U01-AI-034989; NIAID: Stephen J. Gange U01-AI-042590; National Institute of Child Health and Human Development (NICHD): Marek J. Nowicki U01-HD-032632; and UCSF Clinical and Translational Science Institute: Peter Bacchetti UL1-TR000004.",

year = "2020",

month = feb,

day = "1",

doi = "10.1002/cpt.1605",

language = "English (US)",

volume = "107",

pages = "315--318",

journal = "Clinical pharmacology and therapeutics",

issn = "0009-9236",

publisher = "Nature Publishing Group",

number = "2",

}

TY - JOUR

T1 - Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women

AU - Women's Interagency HIV Study

AU - Tamraz, Bani

AU - Huang, Yong

AU - French, Audrey L.

AU - Kassaye, Seble

AU - Anastos, Kathryn

AU - Nowicki, Marek J.

AU - Gange, Stephen

AU - Gustafson, Deborah R.

AU - Bacchetti, Peter

AU - Greenblatt, Ruth M.

AU - Hysi, Pirro G.

AU - Aouizerat, Bradley E.

N1 - Funding Information: University of California San Francisco (UCSF) -Gladstone Center For AIDS Research Grant: Bani Tamraz P30 A1027763; National Institute of Allergy and Infectious Diseases (NIAID): Kathryn Anastos U01-AI-035004; NIAID: Deborah R. Gustafson U01-AI-031834; NIAID: Audrey L. French U01-AI-034993; NIAID: Seble Kassaye U01-AI-034994; NIAID: Ruth M. Greenblatt, Bradley E. Aouizerat U01-AI-034989; NIAID: Stephen J. Gange U01-AI-042590; National Institute of Child Health and Human Development (NICHD): Marek J. Nowicki U01-HD-032632; and UCSF Clinical and Translational Science Institute: Peter Bacchetti UL1-TR000004.

PY - 2020/2/1

Y1 - 2020/2/1

UR - http://www.scopus.com/inward/record.url?scp=85073961740&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85073961740&partnerID=8YFLogxK

U2 - 10.1002/cpt.1605

DO - 10.1002/cpt.1605

M3 - Comment/debate

C2 - 31562781

AN - SCOPUS:85073961740

SN - 0009-9236

VL - 107

SP - 315

EP - 318

JO - Clinical pharmacology and therapeutics

JF - Clinical pharmacology and therapeutics

IS - 2

ER -

Association of Pharmacogenetic Markers With Atazanavir Exposure in HIV-Infected Women

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this